This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shahid, H Articles by Amoaku, W M Search for Related Content PubMed PubMed Citation Articles by Shahid, H Articles by Amoaku, W M

The management of retinal vein occlusion: is interventional ophthalmology the way forward?

¹ Prince Charles Eye Unit, King Edward VII Hospital, Windsor SL4 3DP, UK
² Department of Ophthalmology, Southampton General Hospital, Southampton SO16 6YD, UK
³ Academic Department of Ophthalmology, University of Nottingham, Eye, Ear, Nose and Throat Centre, Queen’s Medical Centre, Nottingham NG7 2UH, UK

Correspondence to:
Correspondence to:
MrW M Amoaku
Academic Department of Ophthalmology, University of Nottingham, Eye, Ear, Nose and Throat Centre, Queen’s Medical Centre, Nottingham NG7 2UH, UK; wma{at}nottingham.ac.uk

Retinal vein occlusions (RVO) are the second commonest sight threatening vascular disorder. Despite its frequency treatments for RVO are unsatisfactory and include several that have not been tested by large, well designed, prospective, randomised controlled trials. There is also the lack of long term follow up in many of the available small uncontrolled studies, and the timings of interventions are haphazard. This review aims to evaluate the current knowledge relating to the pathogenesis, suggested treatments for the different types of RVO, and their complications. Isovolaemic haemodilution is of limited benefit and should be avoided in patients with concurrent cardiovascular, renal, or pulmonary morbidity. Evidence to date does not support any therapeutic benefit from radial optic neurotomy, optic nerve decompression, or arteriovenous crossing sheathotomy on its own. Vitrectomy combined with intravenous thrombolysis may offer promise for central RVO. Similarly, vitrectomy combined with arteriovenous sheathotomy intravenous tissue plasminogen activator may offer benefits for branch RVO. RVOs occur at significantly high frequency to allow future prospective randomised controlled studies to be conducted to evaluate the role of different therapeutic modalities singly or in combination.

Abbreviations: A-V, arteriovenous; BRVO, branch retinal vein occlusion; BVOS, Branch Vein Occlusion Study; CRVO, central retinal vein occlusion; CVOS, Central Vein Occlusion Study; ETDRS, Early Treatment Diabetic Retinopathy Study; MVR, microvitreoretinal; PRP, panretinal photocoagulation; RVO, retinal vein occlusion; t-PA, tissue plasminogen activator; VEGF, vascular endothelial growth factor

Keywords: retinal vein occlusion; steroids

This article has been cited by other articles:

				N. Horio Can the integrity of the photoreceptor layer explain visual acuity in branch retinal vein occlusion? Br. J. Ophthalmol., December 1, 2007; 91(12): 1575 - 1576. [Full Text] [PDF]

				Q. Qian, B. R. Younge, and V. E. Torres Retinal arterial and venous occlusions in patients with ADPKD Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1769 - 1771. [Full Text] [PDF]